Quarterly report pursuant to Section 13 or 15(d)

Note 8 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details)

v3.19.3
Note 8 - Note purchase agreement and consulting agreement with G FarmaLabs Limited: Schedule of Notes receivable from G Farma (Details) - USD ($)
Sep. 30, 2019
Dec. 31, 2018
Details    
Real estate note $ 111,009 $ 111,843
Working capital note 934,042 909,507
Impairment recorded (1,045,051) 0
Note receivable discount 0 (7,591)
Accrued interest 0 3,067
Less current portion 0 (45,173)
Long term portion of notes receivable $ 0 $ 971,653